SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Vascular and Endovascular Surgery
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gürbüz, A.
Right arrow Articles by Yakut, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gürbüz, A.
Right arrow Articles by Yakut, C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Hydroxyethyl Starch (HES) as a Priming Solution in Cardiopulmonary Bypass

Ali Gürbüz

Kosuyolu Heart and Research Center, Istanbul, Turkey

Turan Berki

Kosuyolu Heart and Research Center, Istanbul, Turkey

Esat Akinci

Kosuyolu Heart and Research Center, Istanbul, Turkey

Tuncer Koçak

Kosuyolu Heart and Research Center, Istanbul, Turkey

Cevat Yakut

Kosuyolu Heart and Research Center, Istanbul, Turkey

Various priming solutions are currently used to prime heart-lung machines for cardiac operations. Hemodilution has resulted in considerable conservation of blood, as well as diminution of plasma and corpuscle damage, by decreasing the concentration of these elements in blood during extracorporeal circulation. Controversy has existed regarding the relative efficacy of various hemodilution solutions. In this prospective study two groups of similar open-heart patients, the first receiving hydroxyethyl starch (HES) and the second 5% albumin as a priming solution were compared. Hematocrit, platelet counts, plasma fibrinogen levels, postoperative drainage, prothrombin and partial thromboplastin time, urine output, and administration of blood products were investigated and compared. There were no differences in chest tube drainage, blood use, urine output, coagulation, and hematologic and hemodynamic parameters, except for an early postoperative increase in platelet count in the HES group. HES is a safe, effective, inexpensive volume expander in cardiac surgery patients.

Vascular and Endovascular Surgery, Vol. 25, No. 4, 308-314 (1991)
DOI: 10.1177/153857449102500409
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement